Get the Stockscreener App
0.00
100.00%
-6.81
Portage Biotech Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.
See More
Previous Close:
$6.81
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$15.86M
Revenue:
-
Net Income/Loss:
$-67.28M
P/E Ratio:
0.00
EPS:
-94.66
Net Cash Flow:
$-9.80M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$15.82
Portage Biotech Inc Stock (PRTG) Company Profile
Compare PRTG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRTG
Portage Biotech Inc
|
0.00 | 15.86M | 0 | -67.28M | -9.80M | -94.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.90 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
470.27 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
576.42 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
815.61 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
316.15 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Portage Biotech Inc Stock (PRTG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
| Mar-07-22 | Initiated | H.C. Wainwright | Buy |
| Sep-21-21 | Initiated | Oppenheimer | Outperform |
| Sep-02-21 | Initiated | B. Riley Securities | Buy |
| Aug-19-21 | Initiated | Cantor Fitzgerald | Overweight |
Portage Biotech Inc Stock (PRTG) Latest News
Is Portage Biotech Inc. stock entering bullish territoryJuly 2025 Levels & Technical Entry and Exit Tips - newser.com
Technical signs of recovery in Portage Biotech Inc.Portfolio Return Summary & Low Drawdown Momentum Ideas - newser.com
Technical analysis overview for Portage Biotech Inc. stockTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
Will Portage Biotech Inc. benefit from macro trendsJuly 2025 Big Picture & Low Drawdown Investment Ideas - newser.com
Reversal indicators forming on Portage Biotech Inc. stockTake Profit & Weekly Watchlist of Top Performers - newser.com
Risk adjusted return profile for Portage Biotech Inc. analyzed2025 Dividend Review & Community Consensus Trade Signals - newser.com
Does Portage Biotech Inc. fit your quant trading modelWeekly Market Summary & Advanced Technical Analysis Signals - newser.com
Real time pattern detection on Portage Biotech Inc. stockAnalyst Upgrade & Consistent Profit Focused Trading Strategies - newser.com
Relative strength of Portage Biotech Inc. in sector analysisJuly 2025 Summary & Proven Capital Preservation Tips - newser.com
AlphaTON Capital Corp Enters ATM Agreement with Chardan Capital Markets - MSN
Short interest data insights for Portage Biotech Inc.Weekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Real time breakdown of Portage Biotech Inc. stock performanceMarket Trend Report & Community Verified Watchlist Alerts - newser.com
How Future Regulation Could Impact Starcom Information Technology Limited ProfitabilityMerger & Acquisition Updates & Market Monitoring and Alerts - earlytimes.in
Portage Biotech Inc Stock Analysis and ForecastShort Selling Opportunities & Fast Profit Trading Ideas - earlytimes.in
How Portage Biotech Inc. stock compares to growth peers2025 Growth vs Value & Low Risk Profit Maximizing Plans - newser.com
Earnings visualization tools for Portage Biotech Inc.July 2025 Closing Moves & Target Return Focused Stock Picks - newser.com
What analysts say about Portage Biotech Inc stockProtective Put Strategies & Exceptional Growth Investment - earlytimes.in
Portage Biotech (NASDAQ:PRTG) Trading Up 9.6% – What’s Next? - Defense World
AlphaTON Capital to acquire 51% stake in Animoca’s gaming arm GAMEE - Crypto News
AlphaTON Capital to acquire 51% stake in Animoca’s gaming arm GAMEEAlphaTON’s TON strategy - Bitget
Published on: 2025-10-01 03:03:47 - earlytimes.in
What drives Portage Biotech Inc stock priceMarket Breadth Indicators & Investor Community Interactions - earlytimes.in
Portage Biotech Inc Stock (PRTG) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.09%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):